Seminar-From Base Pairs to Bedside: Targeted Antisense Therapeutics to Modulate Splicing or NMD The development of Spinraza, the first effective therapy for Spinal Muscular Atrophy, Adrian R. Krainer, Cold Spring […]

New Jersey Alliance for Clinical and Translational Science (NJ ACTS) RFA: Partnership & Innovation Pilot Grant Program, Application Deadline: Tuesday, September 3rd, 2019